ArticlePLoS pathogens2025

Engineering a multivalent antibody nanoparticle to overcome SARS-CoV-2 Omicron immune evasion.

Hui Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.